Update on NELSON including its cost-effectiveness analysis

H. De Koning (Rotterdam, Netherlands)

Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Session: NELSON: the Trafalgar of lung cancer screening?
Session type: Symposium
Number: 1553

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. De Koning (Rotterdam, Netherlands). Update on NELSON including its cost-effectiveness analysis. International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: